For Congenital Deafness, a Chinese Trial Opens a Path to Sound
The world’s first clinical trial on congenital deafness gene therapy showed that injecting a missing gene back into ear cells can restore hearing.
Researchers in China have initiated the world's first clinical trial for treating congenital deafness using gene therapy. This groundbreaking approach involves introducing a missing gene directly into the ear cells of patients born deaf. Early results suggest that this intervention can successfully restore hearing.
This trial offers a potential new therapeutic avenue for individuals born with congenital deafness, a condition previously considered largely untreatable.
📌 Kaynak
Bu özet Sixth Tone kaynağından otomatik derlenmiştir. Tamamı için orijinal habere gidin.
Orijinal haberi oku →